Michael Goller

Michael Goller PhD is a seasoned professional in the pharmaceutical industry with extensive experience in respiratory product development. Currently serving as Chief Project Officer at Transpire Bio since April 2023, Michael is responsible for the product development strategy and project management aimed at improving patient access to respiratory medicines. Previous roles include Head of Pharmaceutical Development Respiratory at Sandoz, where Michael led a team of over 20 experts, and Director Program Management Respiratory, overseeing global DPI and MDI projects. At Lupin Pharmaceuticals, Michael was the Senior Director and Program Leader for inhalation product development, which included various drug delivery systems. Earlier career highlights include a Director position at Teva Pharmaceuticals, where Michael was pivotal in the EMA submission and approval of DuoResp® Spiromax®, and leadership roles at Chemo and IVAX Pharmaceuticals focusing on inhalation R&D. Michael holds multiple post-doctoral and doctoral degrees in Physical Chemistry and Food Science from reputable universities.